US Stock MarketDetailed Quotes

IBO Impact BioMedical

Watchlist
  • 388.500
  • 0.0000.00%
Close Jul 5 09:30 ET
4.47BMarket Cap-961633P/E (TTM)

Impact BioMedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
29.78%-712K
-27.16%-2.85M
-19.28%-433K
16.33%-671K
-34.74%-733K
-90.24%-1.01M
0.00%-2.24M
63.88%-363K
-62.77%-802K
-62.74%-544K
Net income from continuing operations
-17.55%-998K
39.26%-4.41M
62.54%-1.26M
49.79%-1.18M
-40.18%-1.12M
-13.81%-849K
0.00%-7.26M
37.11%-3.37M
-154.68%-2.34M
-180.72%-799K
Depreciation and amortization
0.00%280K
0.63%1.12M
0.72%280K
0.36%280K
0.72%280K
0.72%280K
0.00%1.11M
0.00%278K
0.17%279K
-0.17%278K
Deferred tax
----
--0
--0
----
----
----
0.00%-621K
-378.12%-1.88M
----
----
Change In working capital
101.35%6K
3.56%436K
8.73%548K
4,420.00%226K
565.22%107K
-584.62%-445K
0.00%421K
39.23%504K
-96.65%5K
77.05%-23K
-Change in receivables
----
---128K
----
----
----
----
--0
----
----
----
-Change in prepaid assets
97.47%-2K
273.33%104K
328.57%96K
-288.46%-49K
2,042.86%136K
-113.51%-79K
0.00%-60K
-320.00%-42K
866,766.67%26K
83.72%-7K
-Change in payables and accrued expense
102.19%8K
-4.37%460K
6.23%580K
412.07%181K
209.52%65K
-1,207.14%-366K
0.00%481K
66.46%546K
-160.47%-58K
-47.60%21K
Cash from discontinued investing activities
Operating cash flow
29.78%-712K
-27.16%-2.85M
-19.28%-433K
16.33%-671K
-34.74%-733K
-90.24%-1.01M
0.00%-2.24M
63.88%-363K
-62.77%-802K
-62.74%-544K
Investing cash flow
Cash flow from continuing investing activities
0
95.70%-15K
100.36%1K
0.00%-1K
-134.38%-11K
96.19%-4K
0.00%-349K
-103.37%-275K
99.96%-1K
101.15%32K
Net PPE purchase and sale
--0
93.48%-18K
--0
---1K
---12K
---5K
0.00%-276K
---276K
--0
--0
Net investment purchase and sale
----
--0
--0
--0
----
----
0.00%-65K
--0
--0
-102.45%-53K
Net other investing changes
----
137.50%3K
0.00%1K
--0
-98.82%1K
101.08%1K
0.00%-8K
-99.98%1K
99.93%-1K
103.07%85K
Cash from discontinued investing activities
Investing cash flow
--0
95.70%-15K
100.36%1K
0.00%-1K
-134.38%-11K
96.19%-4K
0.00%-349K
-103.37%-275K
99.96%-1K
101.15%32K
Financing cash flow
Cash flow from continuing financing activities
-29.89%713K
12.49%2.87M
-56.96%232K
12.55%870K
22.30%746K
62.72%1.02M
0.00%2.55M
107.46%539K
-73.36%773K
-80.50%610K
Net issuance payments of debt
-29.89%713K
12.49%2.87M
-56.96%232K
12.55%870K
22.30%746K
62.72%1.02M
0.00%2.55M
107.46%539K
-73.36%773K
-80.50%610K
Cash from discontinued financing activities
Financing cash flow
-29.89%713K
12.49%2.87M
-56.96%232K
12.55%870K
22.30%746K
62.72%1.02M
0.00%2.55M
107.46%539K
-73.36%773K
-80.50%610K
Net cash flow
Beginning cash position
-50.00%1K
-95.65%2K
99.01%201K
-97.71%3K
-96.97%1K
-95.65%2K
0.00%46K
8.60%101K
78.72%131K
-54.17%33K
Current changes in cash
200.00%1K
97.73%-1K
-102.02%-200K
760.00%198K
-97.96%2K
92.31%-1K
0.00%-44K
-52.31%-99K
-249.63%-30K
--98K
End cash Position
100.00%2K
-50.00%1K
-50.00%1K
99.01%201K
-97.71%3K
-96.97%1K
0.00%2K
0.00%2K
8.60%101K
78.72%131K
Free cash flow
30.13%-712K
-13.94%-2.87M
32.24%-433K
16.21%-672K
-36.95%-745K
-91.18%-1.02M
0.00%-2.52M
50.12%-639K
-62.77%-802K
-62.74%-544K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 29.78%-712K-27.16%-2.85M-19.28%-433K16.33%-671K-34.74%-733K-90.24%-1.01M0.00%-2.24M63.88%-363K-62.77%-802K-62.74%-544K
Net income from continuing operations -17.55%-998K39.26%-4.41M62.54%-1.26M49.79%-1.18M-40.18%-1.12M-13.81%-849K0.00%-7.26M37.11%-3.37M-154.68%-2.34M-180.72%-799K
Depreciation and amortization 0.00%280K0.63%1.12M0.72%280K0.36%280K0.72%280K0.72%280K0.00%1.11M0.00%278K0.17%279K-0.17%278K
Deferred tax ------0--0------------0.00%-621K-378.12%-1.88M--------
Change In working capital 101.35%6K3.56%436K8.73%548K4,420.00%226K565.22%107K-584.62%-445K0.00%421K39.23%504K-96.65%5K77.05%-23K
-Change in receivables -------128K------------------0------------
-Change in prepaid assets 97.47%-2K273.33%104K328.57%96K-288.46%-49K2,042.86%136K-113.51%-79K0.00%-60K-320.00%-42K866,766.67%26K83.72%-7K
-Change in payables and accrued expense 102.19%8K-4.37%460K6.23%580K412.07%181K209.52%65K-1,207.14%-366K0.00%481K66.46%546K-160.47%-58K-47.60%21K
Cash from discontinued investing activities
Operating cash flow 29.78%-712K-27.16%-2.85M-19.28%-433K16.33%-671K-34.74%-733K-90.24%-1.01M0.00%-2.24M63.88%-363K-62.77%-802K-62.74%-544K
Investing cash flow
Cash flow from continuing investing activities 095.70%-15K100.36%1K0.00%-1K-134.38%-11K96.19%-4K0.00%-349K-103.37%-275K99.96%-1K101.15%32K
Net PPE purchase and sale --093.48%-18K--0---1K---12K---5K0.00%-276K---276K--0--0
Net investment purchase and sale ------0--0--0--------0.00%-65K--0--0-102.45%-53K
Net other investing changes ----137.50%3K0.00%1K--0-98.82%1K101.08%1K0.00%-8K-99.98%1K99.93%-1K103.07%85K
Cash from discontinued investing activities
Investing cash flow --095.70%-15K100.36%1K0.00%-1K-134.38%-11K96.19%-4K0.00%-349K-103.37%-275K99.96%-1K101.15%32K
Financing cash flow
Cash flow from continuing financing activities -29.89%713K12.49%2.87M-56.96%232K12.55%870K22.30%746K62.72%1.02M0.00%2.55M107.46%539K-73.36%773K-80.50%610K
Net issuance payments of debt -29.89%713K12.49%2.87M-56.96%232K12.55%870K22.30%746K62.72%1.02M0.00%2.55M107.46%539K-73.36%773K-80.50%610K
Cash from discontinued financing activities
Financing cash flow -29.89%713K12.49%2.87M-56.96%232K12.55%870K22.30%746K62.72%1.02M0.00%2.55M107.46%539K-73.36%773K-80.50%610K
Net cash flow
Beginning cash position -50.00%1K-95.65%2K99.01%201K-97.71%3K-96.97%1K-95.65%2K0.00%46K8.60%101K78.72%131K-54.17%33K
Current changes in cash 200.00%1K97.73%-1K-102.02%-200K760.00%198K-97.96%2K92.31%-1K0.00%-44K-52.31%-99K-249.63%-30K--98K
End cash Position 100.00%2K-50.00%1K-50.00%1K99.01%201K-97.71%3K-96.97%1K0.00%2K0.00%2K8.60%101K78.72%131K
Free cash flow 30.13%-712K-13.94%-2.87M32.24%-433K16.21%-672K-36.95%-745K-91.18%-1.02M0.00%-2.52M50.12%-639K-62.77%-802K-62.74%-544K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg